LEADER 01681nas  2200601-  450 
001 996208494603316
005 20211118213022.0
035   $a(DE-599)ZDB2706248-X
035   $a(OCoLC)824458127
035   $a(CKB)3400000000087254
035   $a(CONSER)--2013250616
035   $a(EXLCZ)993400000000087254
100   $a20130115a20129999  ---            -
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aLeukemia research reports
210  1$a[Oxford, England] :$cElsevier Ltd.,$d2012-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a2213-0489 
531   $aLEUK RES REP
531 10$aLeuk Res Rep
606   $aLeukemia$vPeriodicals
606   $aLymphomas$vPeriodicals
606   $aMultiple myeloma$vPeriodicals
606   $aLeukemia$2fast$3(OCoLC)fst00996894
606   $aLymphomas$2fast$3(OCoLC)fst01004321
606   $aMultiple myeloma$2fast$3(OCoLC)fst01028990
606   $aLeukemia
606   $aLymphoma
606   $aMultiple Myeloma
606   $aHematologic Neoplasms
608   $aPeriodicals.$2fast
608   $aPeriodicals.
610   $aHematologic Diseases
615  0$aLeukemia
615  0$aLymphomas
615  0$aMultiple myeloma
615  7$aLeukemia.
615  7$aLymphomas.
615  7$aMultiple myeloma.
615 12$aLeukemia.
615 22$aLymphoma.
615 22$aMultiple Myeloma.
615 22$aHematologic Neoplasms.
676   $a616.99/419
906   $aJOURNAL
912   $a996208494603316
996   $aLeukemia research reports$92098315
997   $aUNISA